SUMC in the News (10/03/08)
Print media coverage
New York Times, 10/03/08
Top psychiatrist failed to report drug income
This story details how a psychiatrist at Emory University allegedly failed to report income from drug makers to the university, in violation of university and federal rules. It is the latest in a series of conflict-of-interest disclosures made as part of a Congressional inquiry led by Sen. Charles Grassley (R-Iowa). Stanford is mentioned in the story. A similar piece was also prepared by the Wall Street Journal.
San Francisco Business Times, 10/03/08
OncoMed spins first antibody into the clinic
This article discusses a Phase I study by OncoMed Pharmaceuticals, Inc. on monoclonal antibody treatments and cancer cells. The work of Michael Clarke, the Karel H. and Avice N. Beekhuis Professor in Cancer Biology and the associate director of the Stem Cell Biology and Regenerative Medicine Institute at Stanford, is referenced in this story, which also appears in the San Jose/Silicon Valley Business Journal.
Wall Street Journal, 10/02/08
Science journal/The body as bacterial landlord
Trillions of microbes living in the human body can cause some harm but also afford protection. David Relman, professor of infectious disease and of microbiology and immunology, is quoted in this article.
San Jose/Silicon Valley Business Journal, 10/02/08
StemCells gets grant to fight hepatitis C
StemCells Inc. announced yesterday it was awarded a $305,000 grant from the National Institute of Diabetes and Digestive and Kidney Diseases to research and develop a potential cell-based therapy for liver disease arising from infection by the hepatitis C virus. The studies will be done in collaboration with Jeffrey Glenn, associate professor of gastroenterology and hepatology.
Office of Communication